691 related articles for article (PubMed ID: 22331423)
1. Role of microRNAs in the regulation of breast cancer stem cells.
Liu S; Clouthier SG; Wicha MS
J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
[TBL] [Abstract][Full Text] [Related]
2. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
[TBL] [Abstract][Full Text] [Related]
3. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
[TBL] [Abstract][Full Text] [Related]
4. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
6. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.
Louie E; Nik S; Chen JS; Schmidt M; Song B; Pacson C; Chen XF; Park S; Ju J; Chen EI
Breast Cancer Res; 2010; 12(6):R94. PubMed ID: 21067584
[TBL] [Abstract][Full Text] [Related]
7. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Liu S; Cong Y; Wang D; Sun Y; Deng L; Liu Y; Martin-Trevino R; Shang L; McDermott SP; Landis MD; Hong S; Adams A; D'Angelo R; Ginestier C; Charafe-Jauffret E; Clouthier SG; Birnbaum D; Wong ST; Zhan M; Chang JC; Wicha MS
Stem Cell Reports; 2014 Jan; 2(1):78-91. PubMed ID: 24511467
[TBL] [Abstract][Full Text] [Related]
9. EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells.
Dillard C; Kiyohara M; Mah V; McDermott SP; Bazzoun D; Tsui J; Chan AM; Haddad G; Pellegrini M; Chang YL; Elshimali Y; Wu Y; Vadgama JV; Kim SR; Goodglick L; Law SM; Patel DD; Dhawan P; O'Brien NA; Gordon LK; Braun J; Lazar G; Wicha MS; Wadehra M
Mol Cancer Ther; 2020 Aug; 19(8):1682-1695. PubMed ID: 32451329
[TBL] [Abstract][Full Text] [Related]
10. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
[TBL] [Abstract][Full Text] [Related]
11. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
12. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.
Fritz AJ; Hong D; Boyd J; Kost J; Finstaad KH; Fitzgerald MP; Hanna S; Abuarqoub AH; Malik M; Bushweller J; Tye C; Ghule P; Gordon J; Frietze S; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2020 Oct; 235(10):7261-7272. PubMed ID: 32180230
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H; Srour EF; Badve S
Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
[TBL] [Abstract][Full Text] [Related]
17. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
18. The role of microRNAs in breast cancer stem cells.
Schwarzenbacher D; Balic M; Pichler M
Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
